|
BLZF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.8627999999985E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.62979999963309E-07 |
| Normal-vs-Stage2 |
4.989600E-02 |
| Normal-vs-Stage3 |
7.015400E-01 |
| Normal-vs-Stage4 |
3.907200E-01 |
| Stage1-vs-Stage2 |
5.270600E-01 |
| Stage1-vs-Stage3 |
9.599700E-03 |
| Stage1-vs-Stage4 |
2.635200E-01 |
| Stage2-vs-Stage3 |
2.148200E-01 |
| Stage2-vs-Stage4 |
5.984400E-01 |
| Stage3-vs-Stage4 |
6.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.14319999999724E-05 |
| Normal-vs-AfricanAmerican |
7.764600E-04 |
| Normal-vs-Asian |
3.740200E-01 |
| Caucasian-vs-AfricanAmerican |
8.978000E-01 |
| Caucasian-vs-Asian |
7.630800E-01 |
| AfricanAmerican-vs-Asian |
6.966600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00839999975733E-07 |
| Normal-vs-Female |
3.121200E-01 |
| Male-vs-Female |
1.060470E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.355300E-03 |
| Normal-vs-Extreme_Weight |
2.03010000032755E-07 |
| Normal-vs-Obese |
6.277700E-02 |
| Normal-vs-Extreme_Obese |
4.784000E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.865400E-01 |
| Normal_Weight-vs-Obese |
3.573000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.692000E-01 |
| Extreme_Weight-vs-Obese |
3.301900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.070400E-01 |
| Obese-vs-Extreme_Obese |
3.703200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.923400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.900200E-03 |
| Normal-vs-Age(61-80Yrs) |
2.28309999994458E-06 |
| Normal-vs-Age(81-100Yrs) |
2.03089999999406E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.053000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.242000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.039700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.613600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.257900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.587200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.73030000000441E-07 |
| Normal-VS-Type2 PRCC |
4.826400E-02 |
| Normal-VS-KIRP CIMP |
6.284400E-01 |
| Normal-VS-Unclassified PRCC |
4.726200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.697700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.678300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.432030E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.878430E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.027200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.192970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.046140E-04 |
| Normal-vs-N1 |
4.640200E-01 |
| Normal-vs-N2 |
2.320100E-02 |
| N0-vs-N1 |
1.235610E-02 |
| N0-vs-N2 |
9.336600E-01 |
| N1-vs-N2 |
2.445000E-01 |
|
|
